No effect of rifaximin on soluble CD163, mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled trial - Kimer, N; Gudmann, N S; Pedersen, J S (PLoS One, 2018)
et al.